Patent litigation attorney
Richard de Bodo
2 tracked appearances — 0 plaintiff · 2 defendant.
Specialty & background
I'll research this attorney's background before writing the summary.
Let me verify the Incyte/Affymetrix case, PTAB experience, and current firm.
Let me check for PTAB/IPR proceedings and confirm the firm chronology.
Richard de Bodo — Patent Litigation Practice Summary
Focus areas. De Bodo is a first-chair patent and trade-secret trial lawyer with a dual life-sciences/technology practice. On the life sciences side, firm bios and press coverage describe Hatch-Waxman and BPCIA/biologics litigation, inventorship disputes, and matters involving DNA microarrays, DNA sequencing, peptide therapies, humanized antibodies, diagnostics, and vaccines. On the technology side, the same sources describe patent and trade-secret work in semiconductors, computer software, Internet search, cybersecurity, consumer electronics, printers/inks, and digital cameras, including ITC and Federal Circuit work. His tracked case, Incyte Genomics, Inc. v. Affymetrix, Inc., sits squarely in the genomics/microarray space: the N.D. Cal. litigation over Affymetrix's array patents and Incyte's RNA-amplification patents, which produced a 2001 Markman ruling and ended in a December 2001 global settlement with cross-licenses (per Incyte's investor release). No Wi-Fi/standard-essential-patent work appears in the record.
Side preference. He is a defense-side lawyer. The tracked list shows two appearances, both for the defendant (Affymetrix, via Irell & Manella), with 0 plaintiff-side entries; one as counsel of record and one as trial counsel. That is consistent with the wider record: the client names in his bios (Pfizer, Broadcom, Qualcomm, Dow Jones, Panasonic, Sharp, Olympus, Ricoh, Seiko Epson, HTC, GlaxoSmithKline, Eli Lilly, Takeda, APP Pharmaceuticals, Abraxis BioScience, Affymetrix, Affymax, United Healthcare, Quidel) are operating companies defending or enforcing their own portfolios — not NPEs/PAEs. He is not an NPE plaintiff's lawyer. One recent docket (E.D.N.Y. No. 1:22-cv-01676, Artec Europe S.A.R.L. v. Shenzhen Creality 3D Technology) shows him acting for a plaintiff asserting 3D-scanning patents, so he is not exclusively defense-side, but portfolio-defense work predominates.
Firm context. His patent litigation career began at Irell & Manella (the firm on both tracked appearances) and has since run through large-firm IP leadership roles: co-chair of Hogan Lovells' U.S. IP practice, co-chair of DLA Piper's patent litigation and life sciences practices (2010 lateral move reported by DLA Piper and the L.A. Business Journal), co-chair of Bingham McCutchen's IP and life sciences groups (2013), and chair of Morgan Lewis's life sciences IP practice. More recently he has practiced at smaller firms — Barton LLP announced his arrival as a Los Angeles partner, and Rimon P.C. announced him among lateral hires; his most recent verified court filings (2024–2025) list Rimon P.C., and the State Bar of California profile shows him active at a Rimon Law Los Angeles address. Treat Barton as a prior, not current, affiliation.
Notable results and PTAB. Reported results (largely firm-summarized rather than independently verified) include a summary judgment and Federal Circuit win for Dow Jones in an Internet-search patent case; a $120 million jury verdict plus worldwide injunction in a software patent and trade-secret case; Hatch-Waxman trial and Federal Circuit victories for Takeda involving a billion-dollar drug; a Hatch-Waxman win and permanent injunction for Abraxis BioScience/APP Pharmaceuticals; and a district court/ITC/Federal Circuit outcome yielding a Federal Circuit DMCA ruling. On the tracked Incyte v. Affymetrix matter, the outcome was mixed — the court invalidated the asserted '992 claims and found no infringement of the '934 and '405 patents, while Affymetrix prevailed in the underlying interferences — and the case settled in 2001. He is described as appearing before the U.S. Patent Office, but I found no verified record of specific IPR, PGR, or CBM proceedings naming him; the tracked data contains no PTAB appearances, so his IPR/PGR volume cannot be confirmed from public sources.
Bar / education (per directory profiles). Harvard College (B.A. 1978) and Harvard Law School (J.D. 1983); admitted in Pennsylvania (1986), California (1987), and D.C. (2010); registered before the Federal Circuit and several regional circuits; former law clerk to Judge James M. Fitzgerald (D. Alaska) and Judge Betty B. Fletcher (9th Cir.). The clerkship and pre-1990 details come from third-party directories (Martindale, Prabook) rather than firm or court sources and should be independently confirmed before use.
Firms
Roles
- counsel of record1
- trial counsel1
Cases (2)
- Δ defendantIncyte Genomics, Inc. v. Affymetrix, Inc.Irell & Manella · counsel of record
- Δ defendantIncyte Genomics, Inc. v. Affymetrix, Inc.Irell & Manella · trial counsel